C4 Therapeutics
CCCC
#7878
Rank
โ‚ฌ0.34 B
Marketcap
3,16ย โ‚ฌ
Share price
5.59%
Change (1 day)
70.24%
Change (1 year)

Revenue for C4 Therapeutics (CCCC)

Revenue in 2026 (TTM): โ‚ฌ29.74 Million

According to C4 Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ30.65 Million. In 2025 the company made a revenue of โ‚ฌ30.6 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ34.19 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for C4 Therapeutics from 2020 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ29.74 M-2.8%
2025 โ‚ฌ30.6 M-10.51%
2024 โ‚ฌ34.19 M82.12%
2023 โ‚ฌ18.77 M-35.23%
2022 โ‚ฌ28.98 M-28.29%
2021 โ‚ฌ40.42 M49.8%
2020 โ‚ฌ26.98 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA